Canaan Partners XI LLC

In its 13F for Q4 2024 (holdings as of December 31, 2024, filed January 21, 2025), Canaan Partners XI LLC reported 3 stock positions worth $77.3 million. Its top holding was Tyra Biosciences (TYRA) at 75.2% of the portfolio, followed by Aeva Technologies (AEVA, 22.7%) and Rallybio (RLYB, 2.1%). Compared with Q3 2024, it reduced 2. The biggest sale was Tyra Biosciences (TYRA, shares −5%).

Most Recent 13F
Q2 2026
Location
MENLO PARK, CA
CIK
0001850694
Portfolio Value
$77.3M (Q4 2024)
SEC Filing
0000950123-25-000423 ↗ filed Jan 21, 2025

Holdings Value

0$50.0M$100.0M$150.0M$200.0M Q1 2024: $90.7M Q1 2024 Q2 2024: $82.6M Q2 2024 Q3 2024: $118.1M Q3 2024 Q4 2024: $77.3M $77.3M Q4 2024 Q1 2025: $66.4M Q1 2025 Q2 2025: $171.8M Q2 2025 Q3 2025: $102.9M Q3 2025 Q4 2025: $136.8M Q4 2025 Q1 2026: $76.1M Q1 2026 Q2 2026: $127.3M Q2 2026

Holdings 3 stocks · $77.3M
TYRA Tyra Biosciences Inc. 75.17% 4,179,857 $58.1M Reduce -5.2%
AEVA Aeva Technologies Inc. 22.72% 3,697,039 $17.6M No change
RLYB Rallybio Corp. 2.11% 1,697,684 $1.6M Reduce -11.2%

Portfolio Sells Q3 2024 → Q4 2024
TYRA Tyra Biosciences Inc. Reduce -5.2% 75.17% −12.63
RLYB Rallybio Corp. Reduce -11.2% 2.11% +0.22

Portfolio Buys Q3 2024 → Q4 2024
None this quarter.

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 3$127.3MAEVA, TYRA, BLNK
Q1 2026 3$76.1MAEVA, TYRA, BLNK
Q4 2025 4$136.8MTYRA, AEVA, RLYB, BLNK
Q3 2025 3$102.9MAEVA, TYRA, RLYB
Q2 2025 4$171.8MAEVA, TYRA, UPBD, RLYB
Q1 2025 4$66.4MTYRA, AEVA, RLYB, UPBD
Q4 2024 3$77.3MTYRA, AEVA, RLYB
Q3 2024 3$118.1MTYRA, AEVA, RLYB
Q2 2024 3$82.6MTYRA, AEVA, RLYB
Q1 2024 3$90.7MTYRA, AEVA, RLYB